Journal Information
Most Often Read
2637
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic reviewA. Cortegiani, M. Ippolito, M. Greco, V. Granone, A. Protti, C. Gregoretti, A. Giarratano, S. Einav, M. Cecconi
Pulmonol. 2021;27:52-66
2637
Open access
Open Article
1612
COVID-19 effects on tuberculosis care in Sierra LeoneD. Buonsenso, F. Iodice, J. Sorba Biala, D. Goletti
Pulmonol. 2021;27:67-9
1612
Open access
Open Article
1394
The role of non-invasive ventilation in weaning and decannulating critically ill patients with tracheostomy: A narrative review of the literatureMiguel Guia, Laura D Ciobanu, Jithin K Sreedharan, Mohamed E. Abdelrahim, Gil Gonçalves, Bruno Cabrita, Jaber S. Alqahtani, Jun Duan, Mohamad El-Khatib, Montserrat Diaz-Abad, Jakob Wittenstein, Habib M.R. Karim, Pradipta Bhakta, Paolo Ruggeri, Giancarlo Garuti, Karen E.A. Burns, Guy W. Soo Hoo, Raffaele Scala, Antonio Esquinas
Pulmonol. 2021;27:43-51
1394
Open access
1335
Translating Idiopathic pulmonary fibrosis guidelines into clinical practiceC. Robalo-Cordeiro, A. Morais
Pulmonol. 2021;27:7-13
1335
Open access
1218
Risk factors for early mortality in patients with pulmonary tuberculosis admitted to the emergency roomR. Singla, B. Raghu, A. Gupta, J.A. Caminero, P. Sethi, D. Tayal, A. Chakraborty, Y. Jain, G.B. Migliori
Pulmonol. 2021;27:35-42
1218
Open access
1195
The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancerA. Sakin, S. Sahin, M.M. atci, N. Yasar, C. Geredeli, F. Aksaray, S. Cihan
Pulmonol. 2021;27:26-34
1195
Open access
1124
The “Big Five” Lung Diseases in CoViD-19 Pandemic – a Google Trends analysisM.T. Barbosa, M. Morais-Almeida, C.S. Sousa, J. Bousquet
Pulmonol. 2021;27:71-2
1124
Open access
1103
Low dose computed tomography of the lung for detection and grading of interstitial lung disease: A systematic simulation studyS. Ley, L. Fidler, H. Schenk, M. Durand, T. Marras, N. Paul, S. Shapera, S. Mittoo
Pulmonol. 2021;27:14-25
1103
Open access
1067
Alpha-1-antitrypsin deficiency (AATD) and spontaneous pneumothorax: Guidelines do not recommend screening for AATD in patients with pneumothorax – What did we find in 10 years of clinical evidence?E. Dias, I. Farinha, F. Costa
Pulmonol. 2021;27:80-1
1067
Open access
926
Tuberculosis — Reaping benefits from COVID-19 in PortugalB.L. Mateiro Gomes, I. Carvalho
Pulmonol. 2021;27:4-6
926
Open access
Open Article
861
Rhodococcus equi infection as inaugural manifestation of idiopathic CD4+ lymphopenia: A rare entity and a therapeutic challengeA. Alves, E. Silva, T. Teixeira, C. Figueiredo, A. Lameirão, M. Vanzeller, C. Ribeiro
Pulmonol. 2021;27:75-7
861
Open access
842
Total volume/week of physical activity: an underused variable of physical activity in daily life in patients with copd and its association with exercise capacityLorena P. Schneider, Felipe V.C. Machado, Antenor Rodrigues, Raquel P. Hirata, Daniele C. Dala Pola, Mariana P. Bertoche, Letícia F. Belo, Ana Carolina dos Reis Andrello, Jéssica Fonseca, Leandro C. Mantoani, Karina C. Furlanetto, Fabio Pitta
Pulmonol. 2021;27:73-5
842
Open access
777
Extracorporeal membranous oxygenation for a severe case of vaping associated lung injuryM.R. Regmi, N. Tandan, P. Parajuli, R. Maini, O.E. Lara Garcia, P. Jagtap, A. Kulkarni
Pulmonol. 2021;27:69-70
777
Open access
749
Wearing masks and the fight against the novel coronavirus (COVID-19)Javad Alizargar
Pulmonol. 2021;27:89
749
Open access
682
Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the maskClaudia Crimi, Annalisa Carlucci
Pulmonol. 2021;27:1-3
682
Open access
Open Article
673
Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?C.S. Kow, S.S. Hasan
Pulmonol. 2021;27:86-7
673
Open access
Open Article
659
First case report in Latin America: Oral treatment of multidrug-resistant tuberculosis with delamanid and bedaquiline in combination with linezolid, moxifloxacin and clofazimine following a DRESS syndrome in a peruvian patientS. Pecho-Silva, A.C. Navarro-Solsol
Pulmonol. 2021;27:77-9
659
Open access
584
Secondary pulmonary alveolar proteinosis in a patient with systemic lupus erythematosusM. Yamasaki, K. Kawamoto, S. Nakano, M. Taniwaki, N. Matsumoto, N. Hattori
Pulmonol. 2021;27:81-3
584
Open access
487
Spontaneous pneumomediastinum: Beyond the risky divingJordi Juanola-Pla, Mireia Carmona-Tomàss, Sonia Casals-Vila
Pulmonol. 2021;27:88-9
487
Open access
Special content about COVID-19
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
